Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research note released on Wednesday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.62 on Wednesday. Retractable Technologies has a twelve month low of $0.56 and a twelve month high of $1.34. The company has a market cap of $18.56 million, a P/E ratio of -1.15 and a beta of 2.06. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The company’s 50-day moving average price is $0.71 and its 200-day moving average price is $0.93.

Insider Activity

In related news, CEO Thomas J. Shaw bought 71,422 shares of the stock in a transaction dated Friday, September 20th. The stock was acquired at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the acquisition, the chief executive officer now owns 14,743,907 shares in the company, valued at approximately $12,090,003.74. This represents a 0.49 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders purchased 179,515 shares of company stock worth $143,037. 55.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVPFree Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.